PMCB

Healthcare Biotechnology

PharmaCyte Biotech, Inc.

$0.39

-0.01 -1.35% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 2:29 PM ET	0.39

Key Stats

Market Cap

4.24M

Avg Volume

201,462

EPS

-$2.31

52W High

$1.51

52W Low

$0.33

Div. Yield

0.0%

Valuation

Forward P/E

-1.04

P/B Ratio

0.37

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(44.0%)

Return on Assets

(8.3%)

Liquidity & Leverage

Current Ratio

40.30

Quick Ratio

40.25

Total Cash

30.51M

Total Debt

About

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

pharmacyte.com